Uede et al., 1997 - Google Patents
Osteopontin, a Coordinator of Host Defense System a Cytokine or an Extracellular Adhesive Protein?Uede et al., 1997
View PDF- Document ID
- 16974007565150824736
- Author
- Uede T
- Katagiri Y
- Iizuka J
- Murakami M
- Publication year
- Publication venue
- Microbiology and immunology
External Links
Snippet
Specific cellular adhesion and migration of cells are important themes in embryonic development, tumor cell metastasis, wound healing and inflammation. Recent advances in our understanding of the molecular basis of cell adhesion and migratory interactions with …
- 108010081689 Osteopontin 0 title abstract description 133
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Uede et al. | Osteopontin, a Coordinator of Host Defense System a Cytokine or an Extracellular Adhesive Protein? | |
Cucchiarini et al. | Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2 | |
RU2496790C2 (en) | Neuroendocrine factors for treating degenerative disorders | |
Libby et al. | Production of platelet-derived growth factor–like mitogen by smooth-muscle cells from human atheroma | |
Eble et al. | Integrins in cancer treatment | |
ES2139889T5 (en) | METHODS AND COMPOSITIONS TO STIMULATE THE OSE CELLS. | |
US7947472B2 (en) | Expression vectors and cell lines expressing vascular endothelial growth factor D | |
JP2003525595A (en) | Differentially expressed gene involved in angiogenesis, polypeptide encoded thereby, and method using the same | |
JP2002542823A (en) | Laminin 2 and how to use it | |
Kalluri | Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis | |
WO2006031353A2 (en) | Vascular endothelial growth factor fusion constructs and uses thereof | |
US6638907B1 (en) | Laminin 8 and methods for its use | |
JP2001514026A (en) | Engineered cells expressing bone morphogenetic proteins | |
JP2002542824A (en) | Recombinant laminin 5 | |
Zhang et al. | Angiopoietin-related growth factor (AGF) supports adhesion, spreading, and migration of keratinocytes, fibroblasts, and endothelial cells through interaction with RGD-binding integrins | |
JP2000095702A (en) | Anticancer agent containing salmosin as active ingredient | |
CA2555792C (en) | Therapeutic administration of the scrambled anti-angiogenic peptide c16y | |
Abrahamson et al. | Development of the glomerular capillary and its basement membrane | |
Stringa et al. | Role of newly synthesized fibronectin in vascular smooth muscle cell migration on matrix-metalloproteinase-degraded collagen | |
Bhatt | The Role of Plasma Fibronectin in Bone Marrow Adipogenesis | |
Schwager et al. | Semaphorin 3A promotes the long-term persistence of human SVF-derived microvascular networks in engineered grafts | |
Liu | Expression and functional characterization of a novel fibronectin in fish and mammals | |
AU765888B2 (en) | Expression vectors and cell lines expressing vascular endothelial growth factor D, and method of treating melanomas | |
Kitagawa et al. | De novo adipogenesis for reconstructive surgery | |
JP2008500264A (en) | Methods and compositions for treating extracellular matrix disorders |